Xu Xing Lu
Directeur/Bestuurslid bij Zhejiang Test Bio-Tech Co. Ltd.
Profiel
Xu Xing Lu is currently an Executive Director at Zhejiang Test Bio-Tech Co. Ltd.
and a Director at Shanghai Xingaofeng Biological Medicine Co., Ltd.
Previously, Mr. Lu worked as the Vice Chairman & General Manager at Zhejiang Yatai Pharmaceutical Co., Ltd.
from 2013 to 2017 and as a Director at Shanghai Newsummit Biopharma Group Co., Ltd.
Actieve functies van Xu Xing Lu
Bedrijven | Functie | Begin |
---|---|---|
Zhejiang Test Bio-Tech Co. Ltd.
Zhejiang Test Bio-Tech Co. Ltd. Medical SpecialtiesHealth Technology Zhejiang Test Bio-Tech Co. Ltd. manufactures and distributes in vitro diagnostic reagents. It engages in clinical biochemical diagnostic reagents, immune diagnostic reagents, molecular diagnostic reagents and other new type of in vitro diagnostic reagents R&D, production and sales service. The company was founded in 2011 and is headquartered in Shaoxing, China. | Directeur/Bestuurslid | - |
Shanghai Xingaofeng Biological Medicine Co., Ltd.
Shanghai Xingaofeng Biological Medicine Co., Ltd. BiotechnologyHealth Technology Part of Zhejiang Yatai Pharmaceutical Co., Ltd., Shanghai Xingaofeng Biological Medicine Co., Ltd. is a biotechnology company based in Shanghai, CN. Shanghai Xingaofeng Biological Medicine Co. was acquired by Zhejiang Yatai Pharmaceutical Co., Ltd. from Green Villa Holdings Ltd. on December 02, 2015 for $141.84 million. The Chinese company engages in the development of biotechnology. The company was founded in 2007. The CEO is Li Yun Wang. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Xu Xing Lu
Bedrijven | Functie | Einde |
---|---|---|
ZHEJIANG YATAI PHARMACEUTICAL CO., LTD. | Algemeen Directeur | 16-05-2017 |
Shanghai Newsummit Biopharma Group Co., Ltd.
Shanghai Newsummit Biopharma Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Newsummit Biopharma Group Co., Ltd. provides new drug development process solutions. Its services include pre-clinical development, clinical development, and assistance in the preparation of the regulatory submission of investigational new drug and new drug applications. The company also involves in the provision of technical services for medical devices research. Shanghai Newsummit Biopharma Group was founded by Jun Ren in 2001 and is headquartered in Shanghai, China. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ZHEJIANG YATAI PHARMACEUTICAL CO., LTD. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Shanghai Newsummit Biopharma Group Co., Ltd.
Shanghai Newsummit Biopharma Group Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Newsummit Biopharma Group Co., Ltd. provides new drug development process solutions. Its services include pre-clinical development, clinical development, and assistance in the preparation of the regulatory submission of investigational new drug and new drug applications. The company also involves in the provision of technical services for medical devices research. Shanghai Newsummit Biopharma Group was founded by Jun Ren in 2001 and is headquartered in Shanghai, China. | Commercial Services |
Zhejiang Test Bio-Tech Co. Ltd.
Zhejiang Test Bio-Tech Co. Ltd. Medical SpecialtiesHealth Technology Zhejiang Test Bio-Tech Co. Ltd. manufactures and distributes in vitro diagnostic reagents. It engages in clinical biochemical diagnostic reagents, immune diagnostic reagents, molecular diagnostic reagents and other new type of in vitro diagnostic reagents R&D, production and sales service. The company was founded in 2011 and is headquartered in Shaoxing, China. | Health Technology |
Shanghai Xingaofeng Biological Medicine Co., Ltd.
Shanghai Xingaofeng Biological Medicine Co., Ltd. BiotechnologyHealth Technology Part of Zhejiang Yatai Pharmaceutical Co., Ltd., Shanghai Xingaofeng Biological Medicine Co., Ltd. is a biotechnology company based in Shanghai, CN. Shanghai Xingaofeng Biological Medicine Co. was acquired by Zhejiang Yatai Pharmaceutical Co., Ltd. from Green Villa Holdings Ltd. on December 02, 2015 for $141.84 million. The Chinese company engages in the development of biotechnology. The company was founded in 2007. The CEO is Li Yun Wang. | Health Technology |